The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: A multiple-variable analysis

Journal of Parenteral and Enteral Nutrition

Volumn 35, Issue 5, 2011, Pages 596-602

  Diamond, Ivan R ^a,b,c,d   De Silva, Nicole T ^a   Tomlinson, George A ^c,d   Pencharz, Paul B ^a,c   Feldman, Brian M ^b,c,d   Moore, Aideen M ^a,b,c,d   Ling, Simon C ^a,c   Wales, Paul W ^a,b,c,d  

^a Group for Improvement of Intestinal Function and Treatment (GIFT)   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Department of Surgery ^*  (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

intestinal failure associated liver disease; parenteral lipids; sepsis

Indexed keywords

AMINO ACID; BILIRUBIN GLUCURONIDE; LIPID;

ABDOMINAL SURGERY; AGE DISTRIBUTION; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; ENTERIC FEEDING; ENTEROPATHY; FAT INTAKE; FEMALE; HUMAN; INFANT; INFANT NUTRITION; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; LIVER DISEASE; MALE; MODEL; PARENTERAL NUTRITION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SMALL INTESTINE; STOMA;

DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INTESTINAL DISEASES; INTESTINES; LIPIDS; LIVER DISEASES; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PARENTERAL NUTRITION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 80052371362     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111413598     Document Type: Article

References (39)

1. Carter BA, Shulman RJ. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2007 ; 4: 277-287 (Pubitemid 46711465)
2. Diamond IR, de Silva N, Pencharz PB, Kim JH, Wales PW. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg. 2007 ; 42: 806-811 (Pubitemid 46719214)
3. Wales PW, de Silva N, Kim J, Lecce L, To T, Moore A. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg. 2004 ; 39: 690-695 (Pubitemid 38637917)
4. Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg. 2005 ; 40: 755-762 (Pubitemid 40724842)
5. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1998 ; 27: 131-137 (Pubitemid 28354942)
6. Fecteau A, Atkinson P, Grant D. Early referral is essential for successful pediatric small bowel transplantation: the Canadian experience. J Pediatr Surg. 2001 ; 36: 681-684 (Pubitemid 32417261)
7. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009 ; 48: 209-215
8. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250: 395-402
9. Tillman E, Lazar L, Crill C, Hak E, Christenen M, Helms R. Improvement or reversal of parenteral nutrition associated liver disease in 6 infants with short bowel syndrome treated with enteral fish oil. Nutr Clin Pract. 2009 ; 24: 159
10. Van Aerde JE, Duerksen DR, Gramlich L, et al. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res. 1999 ; 45: 202-208 (Pubitemid 29075996)
11. Llop JM, Virgili N, Moreno-Villares JM, et al. Phytosterolemia in parenteral nutrition patients: implications for liver disease development. Nutrition. 2008 ; 24: 1145-1152
12. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology. 1993 ; 105: 1806-1813 (Pubitemid 24002799)
13. Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res. 2007 ; 62: 301-306 (Pubitemid 47301479)
14. Heller A, Koch T, Schmeck J, van Ackern K. Lipid mediators in inflammatory disorders. Drugs. 1998 ; 55: 487-496 (Pubitemid 28162068)
15. Broughton KS, Wade JW. Total fat and (n-3):(n-6) fat ratios influence eicosanoid production in mice. J Nutr. 2002 ; 132: 88-94 (Pubitemid 34042460)
16. Grimm H, Tibell A, Norrlind B, et al. Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. JPEN J Parenter Enteral Nutr. 1994 ; 18: 417-421 (Pubitemid 24299609)
17. Beckh K, Kneip S, Arnold R. Direct regulation of bile secretion by prostaglandins in perfused rat liver. Hepatology. 1994 ; 19: 1208-1213 (Pubitemid 24134243)
18. Zaman N, Tam YK, Jewell LD, Coutts RT. Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos. 1997 ; 18: 803-819 (Pubitemid 27517569)
19. Nasr A, Avitzur Y, Ng VL, De Silva N, Wales PW. The use of conjugated hyperbilirubinemia greater than 100 micromol/L as an indicator of irreversible liver disease in infants with short bowel syndrome. J Pediatr Surg. 2007 ; 42: 359-362 (Pubitemid 46161559)
20. Touloukian RJ, Smith GJ. Normal intestinal length in preterm infants. J Pediatr Surg. 1983 ; 18: 720-723 (Pubitemid 14175261)
21. George EI, McCulloch R. Variable selection via Gibbs sampling. J Am Stat Assn. 1993 ; 88: 881-889
22. Andorsky DJ, Lund DP, Lillehei CW, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr. 2001 ; 139: 27-33 (Pubitemid 32613983)
23. Bell RL, Ferry GD, Smith EO, et al. Total parenteral nutrition-related cholestasis in infants. JPEN J Parenter Enteral Nutr. 1986 ; 10: 356-359 (Pubitemid 16070911)
24. Sondheimer JM, Cadnapaphornchai M, Sontag M, Zerbe GO. Predicting the duration of dependence on parenteral nutrition after neonatal intestinal resection. J Pediatr. 1998 ; 132: 80-84 (Pubitemid 28082536)
25. Ghose R, Zimmerman TL, Thevananther S, Karpen SJ. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept. 2004 ; 2: 4
26. Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest. 1998 ; 101: 2092-2100 (Pubitemid 28244093)
27. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000 ; 132: 525-532 (Pubitemid 30171891)
28. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000 ; 24: 345-350
29. Cober MP, Teitelbaum DH. Prevention of parenteral nutrition-associated liver disease: lipid minimization. Curr Opin Organ Transplant. 2010 ; 15: 330-333
30. Zlotkin SH, Stallings VA, Pencharz PB. Total parenteral nutrition in children. Pediatr Clin North Am. 1985 ; 32: 381-400 (Pubitemid 15056442)
31. Canada T, Crill C, Guenter P A.S.P.E.N. Parenteral Nutrition Handbook. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition ; 2009 :
32. Diamond IR, Pencharz PB, Wales PW. Omega-3 lipids for intestinal failure associated liver disease. Semin Pediatr Surg. 2009 ; 18: 239-245
33. Diamond IR, Pencharz PB, Wales PW. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?. Minerva Pediatr. 2009 ; 61: 263-272
34. Hadaway LC. Best-practice interventions: keeping central line infection at bay. Nursing. 2006 ; 36: 58-63
35. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. CDC MMWR Recomm Rep. 2002 ; 51: 1-29
36. Beath SV, Booth IW, Murphy MS, et al. Nutritional care and candidates for small bowel transplantation. Arch Dis Child. 1995 ; 73: 348-350
37. Wales PW, Kosar C, Carricato M, De Silva N, Lang K, Avitzur Y. Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections (CRBSI) in home parenteral nutrition patients with intestinal failure: preliminary experience. J Pediatr Surg. 2011 ; 46 (5). 951-956
38. Vanderhoof JA, Young RJ, Murray N, Kaufman SS. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr. 1998 ; 27: 155-160 (Pubitemid 28354946)
39. Nasr A, Diamond IR, De Silva N, Wales PW. Is the use of parenteral omega-3 lipid emulsions in surgical neonates with mild parenteral nutrition associated cholestasis (PNAC) justified?. J Pediatr Surg. 2010 ; 45: 980-986